Table 1 Participant characteristics by polyp status, Kaiser Permanente Washington, Seattle, Washington, 1998-2007
Patient characteristics | Controls | Adenomas | Serrated polyps | Both Adenomas + Serrated polyps | |
|---|---|---|---|---|---|
(n = 49) | (n = 80) | (n = 33) | (n = 28) | ||
Age in years; Mean (SD) | 59.7 (10.8) | 62.3 (10.4) | 61.7 (9.2) | 62.3 (10.9) | |
Gender; n(%) | Male | 25 (51) | 44 (55) | 13 (39.4) | 13 (46.4) |
Female | 24 (49) | 36 (45) | 20 (60.6) | 15 (53.6) | |
White race; n(%) | 44 (89.8) | 72 (90) | 29 (87.8) | 25 (89.3) | |
Smoking; n(%) | Never | 20 (40.8) | 27 (33.8) | 9 (27.3) | 9 (32.1) |
Former | 22 (44.9) | 50 (62.5) | 20 (60.6) | 14 (50) | |
Current | 7 (14.3) | 3 (3.8) | 4 (12.1) | 5 (17.9) | |
Alcohol use; n(%) | 31 (63.3) | 44 (55) | 22 (66.7) | 18 (64.3) | |
BMI; n(%) | < 25 | 17 (34.7) | 25 (31.3) | 10 (30.3) | 8 (28.6) |
25–29.99 | 19 (38.8) | 37 (46.3) | 10 (30.3) | 9 (32.1) | |
30+ | 13 (26.5) | 17 (21.4) | 13 (39.4) | 11 (39.3) | |
Education; n(%) | <High school | 8 (16.3) | 11 (13.8) | 4 (12.1) | 3 (10.7) |
Some college | 11 (22.5) | 21 (26.3) | 9 (27.3) | 12 (42.9) | |
College + | 30 (61.2) | 48 (60) | 20 (60.6) | 13 (46.4) | |
Anti-inflammatory drug use; n(%) | 26 (53.1) | 41 (51.3) | 17 (51.5) | 10 (35.7) | |
Physical activity ≥60 MET h/wk.; n(%) | 41 (83.7) | 62 (77.5) | 26 (78.8) | 23 (82.1) | |
Relative Telomere length; Median (IQR) | 0.60 (0.56–0.72) | 0.60 (0.50–0.71) | 0.57 (0.45–0.67) | 0.59 (0.51–0.67) | |
Short telomeres; n(%) | T/S < 0.58 or shortest tertilea | 17 (34.7) | 36 (45.6) | 19 (57.8) | 14 (50) |